DOCSLIB.ORG

Perioperative

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text

Load more

Health Care Guideline: Perioperative Index Table Sixth Edition January 2020 1. General Preoperative Management Preoperative Health Screening and Assessment Preoperative Testing Electrocardiogram Chest X-ray Hemoglobin/Hematocrit Testing Potassium/Sodium Testing Renal Function (Creatinine) Testing Pregnancy Testing Hemostasis (Coagulation) Testing Glucose Testing in Nondiabetic Patients Sleep Apnea Nicotine Cessation Preparation for Surgery 2. Perioperative Management of Select Conditions Cardiovascular Considerations Prevention of Endocarditis Anticoagulants/Antithrombotics Diabetes Mellitus 3. Perioperative Opioid Management Preoperative Opioid Management Preoperative Patient Education Preoperative Opioid Risk Assessment and Mitigation Preoperative Opioid Use Intraoperative Pain Management Postoperative Opioid Management Postoperative Opioid Prescribing Postoperative Patient Education Perioperative Considerations for Patients with Opioid Use Disorder (OUD) Patients on Medication-Assisted Treatment (MAT) Patients Not on Medication-Assisted Treatment (MAT) Return to Table of Contents www.icsi.org Copyright © 2020 by Institute for Clinical Systems Improvement 1 Perioperative Sixth Edition /January 2020 Table of Contents Perioperative Perioperative Annotations ..........................................................................................1–59 Guideline Work Opioid Index Table ................................................................................................1 Group Leader Management Evidence Grading .....................................................................................3 Mayo Clinic Subgroup Nicole Varela, MD Members Recommendations Table .................................................................... 4–9 Anesthesiology Allina Health Foreword ..........................................................................................10–11 Justin Hora, PharmD Introduction ................................................................................... 10 Perioperative Pharmacy Guideline Work Scope and Target Population ....................................................... 11 Group Members Entira Family Clinics David Thorson, MD Aims ................................................................................................ 11 Allina Health Family Medicine/Sports Implementation Recommendations Highlights ........................ 11 Joshua Mueller, MD Medicine Internal Medicine Related ICSI Scientific Documents ............................................. 11 Essentia Health Definitions ...................................................................................... 11 Entira Family Clinics Joseph Bianco, MD (formerly of) Internal Medicine Annotations .....................................................................................12–59 Hannah Degallier, PA-C Mark Grimm, MD Quality Improvement Support ...................................................60–63 Family Medicine Anesthesiology Aims and Measures............................................................................... 61 Essentia Health Mark Grimm, MD HealthPartners Implementation Recommendations ................................................... 62 Anne Pylkas, MD Anesthesiology Internal Medicine/ Implementation Tools and Resources ................................................ 62 Fairview Health Addiction Medicine Implementation Tools and Resources Table ...................................... 63 Services Isaac Marsolek, MD Supporting Evidence .......................................................................64–76 Deborah Mielke, MD Physical Medicine & Family Medicine Rehabilitation References ........................................................................................65–75 Joan Kane, APNL, Rebekah Roemer, Appendix ................................................................................................ 76 CRNA PharmD, BCPS Appendix A: Literature Search Description ............................... 76 Nursing/Anesthesia Pharmacy Disclosure of Potential Conflicts of Interest ........................77–80 HealthPartners Hennepin Healthcare Acknowledgements ................................................................................ 81 Louis Millman, MD Charles Reznikoff, MD Internal Medicine Internal Medicine/ Document History and Development .....................................82–84 Rebekah Roemer, Addiction Medicine Document History ................................................................................ 83 PharmD, BCPS Pharmacy Mayo Clinic ICSI Document Development and Revision Process ....................... 84 Adam Jacob, MD Mayo Clinic Anesthesiology Adam Jacob, MD Anesthesiology ICSI Senka Hadzic, MPH Nathaniel Miller, MD Facilitator Family Medicine Jodie Dvorkin, MD, Nicole Varela, MD MPH Anesthesiology Co-Facilitator North Memorial Health Audrey Hansen, MA, Sarah Lippert, MD BSN General Surgery Co-Facilitator University of Minnesota (formerly of) Kathleen Harder, PhD Human Factors www.icsi.org Institute for Clinical Systems Improvement 2 Perioperative Sixth Edition /January 2020 Evidence Grading Literature Search A consistent and defined literature search process is used in the development and revision of ICSI guidelines. See Appendix A for literature search parameters and search terms. In addition to the literature searches, articles were obtained by work group members and ICSI staff. Those vetted by the work group were included in the guideline when appropriate. Methodology ICSI utilizes the Grading of Recommendations Assessment, Development and Evaluation (GRADE) meth- odology system. GRADE involves systematically evaluating the quality of evidence (high, moderate, low, very low) and developing a strength of recommendation (strong, weak). For more detailed information on GRADE, please visit http://www.gradeworkinggroup.org/. In addition, when GRADE methodology could not be applied, the work group developed consensus recommendations. Return to Table of Contents www.icsi.org Institute for Clinical Systems Improvement 3 Perioperative Sixth Edition /January 2020 Recommendations Table The following table is a list of evidence-based recommendations for the Perioperative Guideline based on the review of primary literature and secondary references (in instances where primary literature was not found). Topic Quality of Recommendation(s) Strength of Relevant Resources Evidence Recommendation Preoperative Not A preoperative health screening Consensus Fleisher, 2014 Health applicable and assessment that includes (Guideline); Apfelbaum, Screening and a focused medical history and 2012b (Guideline) Assessment appropriate physical examination should be completed for all patients undergoing a surgical procedure, regardless of setting (unless the procedure involves mild sedation, or local/topical anesthesia). Preoperative Low Do not routinely test all patients Strong Keay, 2019 (Systematic Testing undergoing elective, noncardiac Review); Johansson, surgery. 2013 (Systematic Review); Munro, 1997 The need for testing should be (Systematic Review) guided by individual patient’s clinical risk factors (based on medical history and physical examination) and the risk of major adverse cardiac event (morbidity or mortality) associated with the planned procedure. Chest X-ray Low Do not routinely perform chest Strong Johansson, 2013 X-rays preoperatively unless (Systematic Review); indicated by the review of medical Joo, 2005 (Systematic history and physical examination. Review) Hemoglobin/ Low Do not routinely test for Strong Fowler, 2015 (Meta- Hematocrit hemoglobin preoperatively in Analysis); Johansson, Testing healthy, asymptomatic patients. 2013 (Systematic Review); Munro, 1997 Testing for preoperative hemoglobin (Systematic Review) level should be considered in: 1. Patients with a history of anemia or history suggesting recent blood loss or anemia and the planned procedure may lead to significant blood loss or physiologic stress or 2. Patients with prior or planned anticoagulation (expert consensus). Return to Table of Contents www.icsi.org Institute for Clinical Systems Improvement 4 Perioperative Recommendations Table Sixth Edition /January 2020 Topic Quality of Recommendation(s) Strength of Relevant Resources Evidence Recommendation Potassium/ Low Do not routinely test for potassium Strong Johansson, 2013 Sodium Testing or sodium level preoperatively in (Systematic healthy, asymptomatic patients. Review); Wahr, 1999 (Observational Testing may be indicated in: Study); Munro, 1997 1. Patients who are on diuretic (Systematic Review) therapy, 2. Patients with kidney disease (stages 3–5), 3. Patients on potassium replacement therapy, or 4. Patients undergoing bowel preparation. Renal Function Low Do not routinely test for creatinine Strong Kork, 2015 (Creatinine levels in healthy, asymptomatic (Observational Study), Testing) patients. Johansson, 2013 (Systematic Review) Testing may be indicated in patients with known kidney disease or patients with a comorbid condition (e.g., diabetes, hypertension) that carries increased risk of acute kidney injury or kidney disease. Pregnancy Not Do not routinely conduct urine tests Consensus ACOG, 2019 (Joint Testing Applicable for pregnancy. However, patients of Statement with ASA); childbearing age should be asked if ASA, 2016 (Statement); there is a possibility they might be NICE, 2016 pregnant. (Guideline); Apfelbaum, 2012b (Guideline) Pregnancy testing is indicated in: 1. Patients planning to undergo surgeries involving the uterus
Recommended publications
  • Study Protocol and Statistical Analysis Plan

    Study Protocol and Statistical Analysis Plan

    The University of Texas Southwestern Medical Center at Dallas Institutional Review Board PROJECT SUMMARY Study Title: Ultrasound-guided fascia iliaca compartment block versus periarticular infiltration for pain management after total hip arthroplasty: a randomized controlled trial Principal Investigator: Irina Gasanova, MD Sponsor/Funding Source: Department of Anesthesiology and Pain Management, UT Southwestern Medical School IRB Number: STU 122015-022 NCT Number: NCT02658240 Date of Document: 01 April 2016 Page 1 of 7 Purpose: In this randomized, controlled, observer-blinded study we plan to evaluate ultrasound-guided fascia iliaca compartment block with ropivacaine and periarticular infiltration with ropivacaine for postoperative pain management after total hip arthroplasty (THA). Background: Despite substantial advances in our understanding of the pathophysiology of pain and availability of newer analgesic techniques, postoperative pain is not always effectively treated (1). Optimal pain management technique balances pain relief with concerns about safety and adverse effects associated with analgesic techniques. Currently, postoperative pain is commonly treated with systemic opioids, which are associated with numerous adverse effects including nausea and vomiting, dizziness, drowsiness, pruritus, urinary retention, and respiratory depression (2). Use of regional and local anesthesia has been shown to reduce opioid requirements and opioid-related side effects. Therefore, their use has been emphasized (3, 4, 5, 6). Fascia Iliaca compartment block (FICB) is a field block that blocks the nerves from the lumbar plexus supplying the thigh (i.e., lateral femoral cutaneous femoral and obturator nerves). The obturator nerve is sometimes involved in the FICB but probably plays little role in postoperative pain relief for most surgeries of the hip and proximal femur.
  • Ultrasound-Guided Fascia Iliaca Compartment Block (FICB)

    Ultrasound-Guided Fascia Iliaca Compartment Block (FICB)

    Ultrasound-Guided Fascia Iliaca Compartment Block (FICB) Hip Fracture Any of the following present? 1) Neurologic deficit 2) Multisystem Trauma 3) Allergy to local anesthetic Yes *Anticoagulated patients – physician No discretion Standard Care Procedure Details 1) Document distal neurovascular exam in EPIC 1) PO acetaminophen 2) Consult ortho (do not need to await callback) (1,000mg) 3) Obtain verbal consent from patient 2) Consider 0.1 mg/kg 4) Position Patient and U/S Machine morphine or opioid 5) Order Bupivacaine (dose dependent) a. Max 2 mg/kg equivalent b. i.e. 100 mg safe for 50 kg patient 3) Screening labs, CXR, 6) Standard ASA monitoring (telemetry during procedure with ECG, type and screen continuous pulse oximetry, BP measurement, and IV access) 7) Perform FICB 4) Consult orthopedics and medicine as 8) Inform patients on block characteristics: a. Onset ~ 20 minutes necessary b. Duration ~ 8-12 hours Equipment Required Counseling Ultrasound Machine 1) Linear/Vascular Probe set to “Nerve” Benefits setting for best results Decreases: Anesthetic: 1) Pain 1) 0.5% Bupivacaine (20-30 cc) 2) 1% Lidocaine (3-5 cc) 2) Delirium 3) Opioids Saline (10 cc) 4) Hypoxia Syringes: 1) 30 cc 2) 3-5 cc Risks Needles: 1) Pain at injection site 1) Blunt fill 2) Temporary nerve palsy 2) 25G 3) 18G LP needle 3) Intravascular injection Chloroprep or Alcohol swab(s) 4) Local Anesthetic Systemic Toxicity * (LAST) * LAST (local anesthetic systemic toxicity) 1) Rare and only with intravascular injection which an ultrasound guided approach prevents. 2) Signs include arrhythmias, seizures, convulsions 3) Treatment a.
  • Herestraat 49, B-3000 Leuven Yves Kremer, CU Saint-Luc, Av

    Herestraat 49, B-3000 Leuven Yves Kremer, CU Saint-Luc, Av

    Editor | Prof. Dr. V. Bonhomme CO-Editors | Dr. Y. Kremer — Prof. Dr. M. Van de Velde ACTA ANAESTHESIOLOGICA JOURNAL OF THE BELGIAN SOCIETY OF ANESTHESIOLOGY, RESUSCITATION, PERIOPERATIVE MEDICINE AND PAIN MANAGEMENT (BeSARPP) BELGICA Indexed in EMBASE l EXCERPTA MEDICA ISSN: 2736-5239 Suppl. 1 202071 Master Theses www.besarpp.be Cover-1 -71/suppl.indd 1 12/01/2021 12:37 ACTA ANÆSTHESIOLOGICA BELGICA 2020 – 71 – Supplement 1 EDITORS Editor-in-chief : Vincent Bonhomme, CHU Liège, av. de l’Hôpital 1, B-4000 Liège Co-Editors : Marc Van de Velde, KU Leuven, Herestraat 49, B-3000 Leuven Yves Kremer, CU Saint-Luc, av. Hippocrate, B-1200 Woluwe-Saint-Lambert Associate Editors : Margaretha Breebaart, UZA, Wilrijkstraat 10, B-2650 Edegem Christian Verborgh, UZ Brussel, Laarbeeklaan 101, B-1090 Jette Fernande Lois, CHU Liège, av. de l’Hôpital 1, B-4000 Liège Annelies Moerman, UZ Gent, C. Heymanslaan 10, B-9000 Gent Mona Monemi, CU Saint-Luc, av. Hippocrate, B-1200 Woluwe-Saint-Lambert Steffen Rex, KU Leuven, Herestraat 49, B-3000 Leuven Editorial assistant Carine Vauchel Dpt of Anesthesia & ICM, CHU Liège, B-4000 Liège Phone: 32-4 321 6470; Email: [email protected] Administration secretaries MediCongress Charlotte Schaek and Astrid Dedrie Noorwegenstraat 49, B-9940 Evergem Phone : +32 9 218 85 85 ; Email : [email protected] Subscription The annual subscription includes 4 issues and supplements (if any). 4 issues 1 issue (+supplements) Belgium 40€ 110€ Other Countries 50€ 150€ BeSARPP account number : BE97 0018 1614 5649 - Swift GEBABEBB Publicity : Luc Foubert, treasurer, OLV Ziekenhuis Aalst, Moorselbaan 164, B-9300 Aalst, phone: +32 53 72 44 61 ; Email : [email protected] Responsible Editor : Prof.
  • Smoking Cessation: the Role of the Anesthesiologist

    Smoking Cessation: the Role of the Anesthesiologist

    Society for Ambulatory Anesthesiology Section Editor: Tong J. Gan E REVIEW ARTICLE CME Smoking Cessation: The Role of the Anesthesiologist Amir Yousefzadeh, MD, Frances Chung, MD, FRCPC, David T. Wong, MD, FRCPC, David O. Warner, MD, and Jean Wong, MD, FRCPC * * * † * Smoking increases the risk of postoperative morbidity and mortality. Smoking cessation before surgery reduces the risk of complications. The perioperative period may be a “teachable moment” for smoking cessation and provides smokers an opportunity to engage in long-term smoking cessation. Anesthesiologists as the perioperative physicians are well-positioned to take the lead in this area and improve not only short-term surgical outcomes but also long-term health outcomes and costs. Preoperative interventions for tobacco use are effective to reduce postoperative complications and increase the likelihood of long-term abstinence. If intensive interventions (counseling, pharmacotherapy, and follow-up) are impractical, brief interventions should be implemented in preoperative clinics as a routine practice. The “Ask, Advise, Connect” is a practical strategy to be incorporated in the surgical setting. All anesthesiologists should ask their patients about smoking and strongly advise smokers to quit at every visit. Directly connecting patients to existing counseling resources, such as telephone quitlines, family phy- sicians, or pharmacists using fax or electronic referrals, greatly increases the reach and the impact of the intervention. (Anesth Analg 2016;122:1311–20) moking is a risk factor for several perioperative cessation using Medline (January 1946 to May 2015) and complications,1–5 which is a major concern because EMBASE (January 1974 to May 2015). The following text- smokers comprise a substantial proportion of surgi- word terms were used in our search strategies: smoking S 6,7 cal patients.
  • Fascia Iliaca Block in the Emergency Department

    Fascia Iliaca Block in the Emergency Department

    The Royal College of Emergency Medicine Best Practice Guideline Fascia Iliaca Block in the Emergency Department 1 Revised: July 2020 Contents Summary of recommendations ...................................................................................................... 3 Scope ..................................................................................................................................................... 4 Reason for development ................................................................................................................. 4 Introduction .......................................................................................................................................... 4 Considerations ..................................................................................................................................... 4 Safety of FIB ...................................................................................................................................... 4 Improving safety of FIB .................................................................................................................. 5 Controversies regarding FIB ......................................................................................................... 5 Efficacy of FIB ................................................................................................................................... 6 Procedures within ED ....................................................................................................................
  • Short-Term Preoperative Smoking Cessation and Postoperative Complications: a Systematic Review and Meta-Analysis Arrêt A` Court

    Short-Term Preoperative Smoking Cessation and Postoperative Complications: a Systematic Review and Meta-Analysis Arrêt A` Court

    Can J Anesth/J Can Anesth (2012) 59:268–279 DOI 10.1007/s12630-011-9652-x REPORTS OF ORIGINAL INVESTIGATIONS Short-term preoperative smoking cessation and postoperative complications: a systematic review and meta-analysis Arreˆta` court terme du tabagisme en pre´ope´ratoire et complications postope´ratoires: revue syste´matique de la litte´rature et me´ta-analyse Jean Wong, MD • David Paul Lam, BSc • Amir Abrishami, MD • Matthew T. V. Chan, MBBS • Frances Chung, MBBS Received: 24 August 2011 / Accepted: 1 December 2011 / Published online: 21 December 2011 Ó Canadian Anesthesiologists’ Society 2011 Abstract derive the minimum duration of preoperative abstinence Purpose The literature was reviewed to determine the from smoking required to reduce such complications in risks or benefits of short-term (less than four weeks) adult surgical patients. smoking cessation on postoperative complications and to Source We searched MEDLINE, EMBASE, Cochrane, and other relevant databases for cohort studies and ran- domized controlled trials that reported postoperative complications (i.e., respiratory, cardiovascular, wound- Author contributions Jean Wong was involved in data abstraction, healing) and mortality in patients who quit smoking within interpretation of data, drafting and revising, and final approval of the six months of surgery. Using a random effects model, article. David Paul Lam was involved in data abstraction and drafting meta-analyses were conducted to compare the relative of the article. Amir Abrishami was involved in drafting and revising the article, data analysis, and interpretation of the data. Matthew risks of complications in ex-smokers with varying intervals Chan revised and approved the final version of the article.
  • Education and Implementation of the Fascia Iliaca Block for Acute Hip Fracture Patients

    Education and Implementation of the Fascia Iliaca Block for Acute Hip Fracture Patients

    Education and Implementation of the Fascia Iliaca Block for Acute Hip Fracture Patients Item Type text; Electronic Dissertation Authors Roberts, Chrisanna Marie Citation Roberts, Chrisanna Marie. (2021). Education and Implementation of the Fascia Iliaca Block for Acute Hip Fracture Patients (Doctoral dissertation, University of Arizona, Tucson, USA). Publisher The University of Arizona. Rights Copyright © is held by the author. Digital access to this material is made possible by the University Libraries, University of Arizona. Further transmission, reproduction, presentation (such as public display or performance) of protected items is prohibited except with permission of the author. Download date 07/10/2021 05:44:23 Link to Item http://hdl.handle.net/10150/658627 EDUCATION AND IMPLEMENTATION OF THE FASCIA ILIACA BLOCK FOR ACUTE HIP FRACTURE PATIENTS by Chrisanna Roberts ________________________ Copyright © Chrisanna Roberts 2021 A DNP Project Submitted to the Faculty of the COLLEGE OF NURSING In Partial Fulfillment of the Requirements For the Degree of DOCTOR OF NURSING PRACTICE In the Graduate College THE UNIVERSITY OF ARIZONA 2 0 2 1 2 3 ACKNOWLEDGMENTS I would like to acknowledge my fellow group members, Kaitlin Tilton and Jenna Hernandez for their hard work and collaboration on this project. I would like to acknowledge Dr. Sarah Torabi for chairing this project and academic guidance throughout my doctoral degree. Without her hard work and leadership, this project would not have been possible. I would like to acknowledge Dr. Kristie Hoch and Dr. Chris Herring for their mentorship and educational contributions to my nurse anesthesia practice. I would like to acknowledge Dr. Patricia Daly for her involvement in this project as a committee member.
  • The Anaesthesia Science Viva Book, Second Edition Simon Bricker Index More Information

    The Anaesthesia Science Viva Book, Second Edition Simon Bricker Index More Information

    Cambridge University Press 978-0-521-72644-3 - The Anaesthesia Science Viva Book, Second Edition Simon Bricker Index More information Index A a2-adrenoceptor agonists abciximab 261 local anaesthesia spinal adjuncts 229 abdominal obesity 171 stress response to surgery 175 abnormal placentation, postpartum haemorrhage a2-adrenoceptor blockers, cardiac output 233 (PPH) 383 b-adrenoceptors 239 abnormal respiration 113 adrenaline 179 abnormal waveforms, capnography 292 b-adrenoceptor blockers 237, 238–41 ABO blood group, see blood groups cardiac output 232 absolute humidity 332 cocaine overdose management 254 absolute pressure 318 intraocular pressure 152 absorption atelectasis 136 b2-adrenoceptor blockers 267 acarbose 277 adrenocortical suppression, etomidate 201 acceleromyography 156 AEP, see auditory evoked potentials ACE inhibitors 242 afferents, autonomic nervous system 23 acetylcholine 23 age/ageing 172–4 muscle action potentials 154 subarachnoid (spinal) anaesthesia 83 postjunctional nicotinic receptors 154 air embolism N-acetylcysteine, paracetamol overdose 252 ultrasound 338 acidosis venous cannulation 18 hypercapnic 121 air-filled spaces, nitrous oxide 206 lactic 111 airway(s) acquired immune response, see immune response awareness 284 activated protein C, sepsis management 399 goitre effects 187 active scavenging systems 312 irritation 203–4 acute haemolytic reactions 372 thyroid disease 187 acute lung disease, compliance 120 upper, see upper airways acute normovolaemic haemodilution 371 airway management acute phase proteins, sepsis
  • Health Care Guideline Perioperative Protocol

    Health Care Guideline Perioperative Protocol

    Health Care Guideline Perioperative Protocol How to Cite this Document Card R, Sawyer M, Degnan B, Harder K, Kemper J, Marshall M, Matteson M, Roemer R, Schuller-Bebus G, Swanson C, Stultz J, Sypura W, Terrell C, Varela N. Institute for Clinical Systems Improvement. Perioperative Protocol. Updated March 2014. ICSI Members, Sponsors and organizations delivering care within Minnesota borders, may use ICSI documents in the following ways: • ICSI Health Care Guidelines and related products (hereinafter “Guidelines”) may be used and distributed by ICSI Member and Sponsor organizations as well as organizations delivering care within Minnesota borders. The guidelines can be used and distributed within the organization, to employees and anyone involved in the organization’s process for developing and implementing clinical guidelines. • ICSI Sponsor organizations can distribute the Guidelines to their enrollees and those care delivery organizations a sponsor holds insurance contracts with. • Guidelines may not be distributed outside of the organization, for any other purpose, without prior written consent from ICSI. • The Guidelines may be used only for the purpose of improving the health and health care of Member’s or Sponsor’s own enrollees and/or patients. • Only ICSI Members and Sponsors may adopt or adapt the Guidelines for use within their organizations. • Consent must be obtained from ICSI to prepare derivative works based on the Guidelines. • Appropriate attribution must be given to ICSI on any and all print or electronic documents that reference the Guidelines. All other copyright rights for ICSI Health Care Guidelines are reserved by the Institute for Clinical Systems Improvement. The Institute for Clinical Systems Improvement assumes no liability for any use, adaptations, revisions or modifications made to ICSI Health Care Guidelines by the user or others.
  • The Right Health Care the Right Way Global Case Studies in Reducing Low-Value Care the Right Health Care the Right Way

    The Right Health Care the Right Way Global Case Studies in Reducing Low-Value Care the Right Health Care the Right Way

    A report by the Center for Health Solutions The right health care the right way Global case studies in reducing low-value care The right health care the right way Value-based payment models have the potential to upend traditional patient care and business models. What can your organization do to effectively make the shift and “win” in the new value- based care payment landscape? To learn more about Deloitte’s value-based care practice and our relevant insights, please visit www.deloitte.com/us/ValueBasedCare. Global case studies in reducing low-value care CONTENTS Executive summary | 2 Introduction | 4 The right care | 5 The right setting | 8 Providing care safely | 10 Providing care in the right way | 12 Conclusions and overview of lessons for adoption and innovation | 14 Endnotes | 16 1 The right health care the right way Executive summary OW-VALUE health care—services of low, no, or In these 10 case studies, and throughout the pa- even negative impact on patients, as well as per, we highlight where effective use of technology Lservices delivered in an unsafe or inefficient has made a difference, from seemingly simple fixes manner—is pervasive across the globe. Some widely such as including patient photographs in electronic used services are clinically inappropriate for most health records to improving clinician training with patients under most circumstances. Examples in- Wi-Fi-enabled robots that simulate patients. We clude doing an EEG for an uncomplicated headache also show where emerging applications could make or a CT or MRI for lower back pain in patients with- even more of an impact in the future in terms of im- out signs of a neurological problem.1 More examples proving outcomes or reducing costs.
  • Treatment for Acute Pain: an Evidence Map Technical Brief Number 33

    Treatment for Acute Pain: an Evidence Map Technical Brief Number 33

    Technical Brief Number 33 R Treatment for Acute Pain: An Evidence Map Technical Brief Number 33 Treatment for Acute Pain: An Evidence Map Prepared for: Agency for Healthcare Research and Quality U.S. Department of Health and Human Services 5600 Fishers Lane Rockville, MD 20857 www.ahrq.gov Contract No. 290-2015-0000-81 Prepared by: Minnesota Evidence-based Practice Center Minneapolis, MN Investigators: Michelle Brasure, Ph.D., M.S.P.H., M.L.I.S. Victoria A. Nelson, M.Sc. Shellina Scheiner, PharmD, B.C.G.P. Mary L. Forte, Ph.D., D.C. Mary Butler, Ph.D., M.B.A. Sanket Nagarkar, D.D.S., M.P.H. Jayati Saha, Ph.D. Timothy J. Wilt, M.D., M.P.H. AHRQ Publication No. 19(20)-EHC022-EF October 2019 Key Messages Purpose of review The purpose of this evidence map is to provide a high-level overview of the current guidelines and systematic reviews on pharmacologic and nonpharmacologic treatments for acute pain. We map the evidence for several acute pain conditions including postoperative pain, dental pain, neck pain, back pain, renal colic, acute migraine, and sickle cell crisis. Improved understanding of the interventions studied for each of these acute pain conditions will provide insight on which topics are ready for comprehensive comparative effectiveness review. Key messages • Few systematic reviews provide a comprehensive rigorous assessment of all potential interventions, including nondrug interventions, to treat pain attributable to each acute pain condition. Acute pain conditions that may need a comprehensive systematic review or overview of systematic reviews include postoperative postdischarge pain, acute back pain, acute neck pain, renal colic, and acute migraine.
  • Scientific Programme Wednesday, 26. June 2019 Student Assembly

    Scientific Programme Wednesday, 26. June 2019 Student Assembly

    International Council of Nurses Congress 2019, 27 June - 1 July 2019, Marina Bay Sands, Singapore Scientific Programme Wednesday, 26. June 2019 Side meeting 08:30 - 17:00 Academia Student Assembly The ICN Congress Nursing Student Assembly will be held on Wednesday, 26 June from 09:00 to 17:00 at the Academia at the Singapore General Hospital. Registration will begin at 08:30. Simultaneous interpretation will be provided in English, French and Spanish. The Assembly provides nursing students the opportunity to connect, explore and collaborate on priority issues. Registration to the event 08:30 - 09:00 Welcome, Presentation and Introduction by the Singapore Nurses 09:00 - 09:10 Association, ICN Ice breaker 09:10 - 09:30 ICN – The Global Voice of Nursing 09:30 - 09:43 Nursing Now 09:43 - 09:56 State of the World’s Nursing 09:56 - 10:10 Care To Go Beyond 10:10 - 10:40 Break 10:40 - 11:00 Lost in Transition – Newly qualified Registered Nurses and their 11:00 - 11:20 transition to practice journey Developing the next generation – Lessons learnt from the Emerging 11:20 - 11:50 Nurse Leader Programme Hashtags & Healthcare: Social media and its relationship to mental 11:50 - 12:20 health Q&A 12:20 - 12:40 The future of student engagement at ICN 12:40 - 13:00 Lunch 13:00 - 14:00 Group Work (Breakout rooms) 14:00 - 15:30 Break 15:30 - 15:45 Reports of the group work 15:45 - 16:30 Conclusions of the Assembly 16:30 - 16:45 Page 1 / 168 International Council of Nurses Congress 2019, 27 June - 1 July 2019, Marina Bay Sands, Singapore Scientific Programme Thursday, 27.